Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |